A new paste to quickly stop bleeding without relying on blood clotting
Official title: Hemostatic Bioadhesive Paste for Coagulation-Independent Rapid Control of Bleeding
Funded at Sanaheal, INC. · NIH-11007752 · Data updated 2026-11-12
This study is working on a special paste that helps stop bleeding quickly for patients who take blood thinners or have bleeding disorders, making it safer for them during surgeries.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sanaheal, INC. NIH-funded |
| Lab location | 1 site (Somerville, UNITED STATES) |
| Project start | September 25, 2024 |
| Project end | June 30, 2026 |
| Funding year | 2024 |
| Award (this year) | $1,249,317 |
| NIH project number | 1R44HL176351-01 |
| Project ID | NIH-11007752 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include patients undergoing cardiovascular surgeries or those with bleeding disorders who are at risk of major hemorrhagic events.
✕Less likely to help
Patients who do not have bleeding disorders or are not undergoing procedures that pose a risk of severe bleeding may not benefit from this research.
What this research studies
This research focuses on developing a hemostatic bioadhesive paste that can rapidly control bleeding in patients, particularly those who are on anticoagulant medications or have coagulation disorders. The paste works independently of the body's natural blood clotting mechanisms, providing a solution for high-risk bleeding situations during surgeries. The research involves optimizing and validating this paste to meet FDA regulatory standards before moving to clinical trials. The goal is to ensure that this innovative product can be safely and effectively used in medical settings.
Why it matters
Potential benefit: If successful, this research could provide a new, effective treatment option for patients experiencing severe bleeding, potentially saving lives during critical medical situations.
How similar studies have gone: Previous research has shown promising results with similar hemostatic agents, indicating potential for success with this novel approach.
Where this research is happening
-
Sanaheal, INC.
Somerville, United States Active
Researchers
- Principal investigator: Yuk, Hyunwoo — Sanaheal, INC.
- Study coordinator: Yuk, Hyunwoo
Related research
Other NIH-funded projects on the same topics.
-
Direct measurement of RhD sensitization after early-pregnancy bleeding
This study tests how often Rh immunoglobulin given after bleeding in early pregnancy prevents RhD sensitization in pregnant people.
-
EpiMAX: a new injectable gel that stops GI bleeding quickly and for days
A new injectable hydrogel with epinephrine-loaded microparticles is designed to plug GI bleeds and provide immediate and lasting hemostasis for about 72 hours.
-
Dynamic risk tools to prevent blood clots and bleeding in cancer patients
A new AI-based approach will predict who among people with cancer starting treatment is at higher risk for blood clots or dangerous bleeding, helping doctors tailor preventive care.
-
Bleeding and Platelet Problems in Ehlers-Danlos Syndrome
This NIH grant looks at why people with Ehlers-Danlos syndrome bleed more and how platelet function is involved, with goals that could lead to better care during surgery or emergencies.
-
Long-acting RNA therapy to control fibrinolysis and reduce bleeding
A new RNA treatment delivered in lipids aims to slow down fibrinolysis and lessen bleeding for people with bleeding disorders or severe hemorrhage.
-
Thrombosis and Bleeding Risk in Medical Inpatients
A patient-facing program to better predict who is at risk for blood clots or bleeding during and after hospital stays, and to tailor prevention accordingly.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.